Lonapalene (RS4317) is a topical 5-lipoxygenase (5-LO) inhibitor used in research to study inflammatory skin conditions like psoriasis. Its efficacy in blocking eicosanoid-mediated inflammation has been demonstrated in both in vitro enzymatic assays and in vivo models of dermal inflammation.